Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Heart Lung Transplant. 2016 Sep 12;36(3):331–339. doi: 10.1016/j.healun.2016.08.028

Table 1.

Clinical donor characteristics and operative factors.a

Characteristic PGD (n=14) Control (n=25)
Age, y 50±11 59±8
Sex, male, n(%) 11(78.6) 15(60)
Cause of death 64% trauma, 36% non-trauma 72% trauma, 28% non-trauma
Smoking history, n(%) 9(64.2) 17(68)
 >20 pack-years, n(%) 5(35.7) 8(32)
Last PaO2/FiO2 ratio <300 438±55 477±83
Time on ventilator >72 h 5(25.7) 8(32)
Organ ischemic time
 1st lung ischemic period, min 222±38 198±60
 2nd lung ischemic period, min 295±54 277±57
Cardiopulmonary bypass 4(28.4) 7(28)
ABO-identical compatibility, n(%) 14(100) 25(100)
CMV mismatch (Donor (+) recipient (−)) 5(35.7) 10 (40)
Extracorporeal membrane oxygenation 0/14 0/25
a

Values expressed as mean ± standard deviation, unless indicated otherwise.

Abbreviation: CMV, cytomegalovirus; PGD, primary graft dysfunction.